Atlas Trials

Impact of Two Genetic Variants of OATP1B3 or MRP2 or Rifampin on Systemic Disposition and Biological Efficacy of CCK-8

Clinical trial NCT02507167 · COMPLETED

Trial details

NCT number
NCT02507167
Sponsor
University Medicine Greifswald
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Gastrointestinal Hormones
Start date
2012-11-01
Primary completion
2013-07-01
Enrollment
19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.